School of Medicine
Showing 1-50 of 152 Results
-
Julia Abitbol
Postdoctoral Scholar, Otolaryngology - Head & Neck Surgery
Current Research and Scholarly InterestsMy research interests are to identify genes that may enhance cochlear regeneration in an effort to treat patients with hearing loss.
-
Marta Arenas Jal
Postdoctoral Scholar, Bioengineering
BioMarta holds a PhD in pharmaceutical technology and an Executive MBA. She is passionate about healthcare research and innovation and has several years of experience in leading R&D projects within the pharmaceutical industry. Prior to joining Stanford Biodesign, Marta worked at CIMTI which is an accelerator for health startups that supports innovators to develop and implement solutions that improve healthcare quality and patient outcomes.
Throughout her career, she has demonstrated a strong track record of successfully translating research and innovation into real-world impact. She is a curious, creative, and open-minded person who is always seeking to solve complex problems in order to make a positive impact on patients’ lives. In her current role as Innovation Fellow at Stanford Byers Center for Biodesign, she is part of a team working on developing innovative solutions to address unmet needs in healthcare. -
Mohan Babu Budikote Venkatappa
Postdoctoral Scholar, Genetics
Current Research and Scholarly InterestsLongitudinal host-microbial omics profiling and wearables-based monitoring to understand Autism Spectrum Disorder (ASD), its heterogeneity, and predictors of the diverse symptoms that ASD individuals experience.
-
Shashank Chetty
Postdoctoral Scholar, Radiology
BioMCHRI Post-doctoral Fellow
-
Christina F. Chick
Instructor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsMy research examines the mechanistic contributions of sleep, cognition and affect to the onset and course of psychiatric disorders across the lifespan. I am particularly interested in adolescence as a period during which changes in circadian rhythm, sleep architecture, and sleep behavior co-occur with neuroendocrine development, psychosocial changes, and the onset of many psychiatric disorders. Given that sleep is a highly treatable target, increasing our understanding of the specific contributions of sleep to psychiatric symptom onset may facilitate the development of targeted interventions to mitigate the course of illness.
-
Laetitia Coassolo (Voilquin)
Postdoctoral Scholar, Pathology
BioI received my PharmD from the University of Strasbourg (France) in 2018. I completed my PhD in Oncology and Cell Biology in 2020 in Dr. Catherine Tomasetto's group in IGBMC (France) studying cell metabolism and cell signaling in breast cancer. I am now a postdoctal fellow in Dr. Katrin Svensson lab and I am highly interested in understanding the molecular mechanisms of non-classical hormones in metabolic diseases.
-
Maharshi Krishna Deb
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsI aim to gain insights of the molecular underpinnings that are critical for the specification of human germ cells as well as the episode of epigenetic reprogramming that they undergo which is critical for their development and thereby essential for perpetual propagation of human species. Under co-mentorship of Prof. Azim Surani and Dr. Shiv Grewal,I aim to learn these lessons from this immortal lineage of human germline to identify interventions against various pediatric as well as degenerative
-
Dorien Feyaerts
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsBiomedical scientist and immunologist with a strong background in fetal-maternal immunology that aims to conduct impactful translational research in women’s health to improve the health of mothers and their children.
-
Adina S. Fischer, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
On Leave from 10/10/2022 To 10/09/2023BioDr. Fischer’s research focuses on characterizing risk and resilience factors in depression. She has been awarded an NIH Career Development Award (K23) and Klingenstein Foundation Fellowship in Adolescent Depression to build her program of clinical and translational research at Stanford. Dr. Fischer's program of clinical care focused on the delivery and teaching of evidence-based clinical interventions that enhance resilience, with a focus on addressing the unique stressors encountered in academia and academic medicine that may contribute to risk and resilience in mood and anxiety disorders.
Dr. Fischer’s translational program of research focuses on:
(1) Improving our understanding of protective biomarkers of resilience to depression
(2) Characterizing the effects of cannabis on neurobiological function and depressive symptoms
(3) Developing neurobiologically-guided interventions for depressive disorders, particularly those that co-occur with cannabis and other substance use
Dr. Fischer earned her BSc at the Massachusetts Institute of Technology in Brain and Cognitive Sciences, where she conducted research in the Early Childhood Cognition Laboratory. She then completed the MD/PhD Program at Dartmouth, where she obtained her PhD in in Neuroscience. Dr. Fischer’s doctoral research focused on characterizing the acute effects of cannabis in patients with schizophrenia and co-occurring cannabis use disorder. She then completed the Stanford Psychiatry Residency Training Program as a member of the Research Track, and an NIH funded T-32 postdoctoral research fellowship within the Department of Psychiatry and Behavioral Sciences. -
Jenna Forsyth
Academic Program Professional, Medicine - Med/Infectious Diseases
BioJenna is a research scientist with the School of Medicine and affiliated with the King Center for Global Development, the Woods Institute for the Environment and the Doerr School of Sustainability. She completed her PhD with the Emmett Interdisciplinary Program in Environment and Resources and obtained her Master's in Civil and Environmental Engineering from the University of Washington. Her research brings together principles of environmental science, epidemiology, and behavior change. She develops and evaluates interventions to minimize exposures to contaminants and disease vectors in low-income countries. Her most recent research has focused on lead exposure in South Asia.
-
Connie Fung
Postdoctoral Scholar, Pathology
BioConnie received her B.S. in Microbiology, Immunology, and Molecular Genetics from UCLA, where she conducted research on how the eukaryotic parasite Toxoplasma gondii invades and replicates inside host cells in the lab of Dr. Peter Bradley. Subsequently, she obtained her Ph.D. in Microbiology & Immunology from Stanford University with Dr. Manuel Amieva. Her thesis research involved the use of high-resolution microscopy to study how the bacterium Helicobacter pylori establishes and maintains persistent colonization of the gastric epithelium. Connie joined Dr. Michael Howitt's lab as a postdoctoral research fellow in 2019 and is currently investigating how tuft cells, specialized taste-chemosensory cells, modulate epithelial cell function and mucosal immunity in response to intestinal parasites and commensals.
-
Shivani Gaiha
Instructor, Pediatrics - Adolescent Medicine
BioShivani applies both quantitative and qualitative experimental and implementation research to develop and evaluate public health programs, that may ultimately contribute to healthy behaviors among adolescents. Her current research focuses on three key areas:
(1) Assessing youth patterns of use and perceptions about electronic cigarettes (e-cigarettes or vapes) and other substances;
(2) Understanding why youth use e-cigarettes - the impact of marketing influences and using e-cigarettes to cope with stress; and
(3) Evaluating school-based educational interventions to reduce e-cigarette use.
In addition to research, Shivani enjoys teaching research methods and mentoring residents, fellows, postdoctoral trainees and students.
Through her Ph.D., Shivani developed and evaluated an arts-based educational program to reduce mental-health-related stigma in India. The program had a large, significant and positive effect on participants - they desired greater social proximity to people living with mental health problems. During this time, she also became interested in the intersection between mental health and substance use, a common theme in her interactions with youth. She also refined her skills in statistical analysis, study design and project management. Her interdisciplinary Ph.D. research at the London School of Hygiene and Tropical Medicine was supported by the PHFI-UKC Wellcome Trust Capacity Strengthening Award (2014-18). In 2017, she received the LSHTM Public Engagement Small Grant to strengthen school teachers’ understanding of mental health problems, which resulted in a monthly column in a popular educational magazine, reaching approximately 40,000 Indian teachers every month.
Previously, Shivani designed, implemented and evaluated health communication and behavior change initiatives at the Public Health Foundation of India (PHFI) from 2008-2014. She is especially passionate about designing educational public health programs to break silences around contentious public health issues, using participatory media and entertainment-education. At PHFI, she spearheaded health communication and community engagement programs aimed at changing behavior related to healthy lifestyles, sexual and reproductive health, maternal and neonatal care, menstrual hygiene, avoidable blindness and mental health. In partnership with the Ministry of Health and Family Welfare, Government of India and community-based organizations, she led three educational interventions: a community awareness campaign, which improved treatment-seeking behavior for mental disorders in underserved areas; a website targeting young people to improve their lifestyle; and entertainment-education-based participatory action research to improve sexual and reproductive health. -
Elias Roth Gerrick
Postdoctoral Scholar, Pathology
BioEli received his B.S. in Microbiology and Immunology from U.C. Irvine in 2013, where he worked in the lab of Dr. Celia Goulding. He earned his Ph.D. from Harvard University in 2018 in the lab of Dr. Sarah Fortune, where he studied post-transcriptional regulation of gene expression in Mycobacterium tuberculosis. Eli joined the Howitt lab at Stanford in the summer of 2018, where he is studying the influence of protozoan members of the microbiome on intestinal immunity.
-
Ruth Margaret Gibson
Postdoctoral Scholar, Medicine
BioDr. Ruth M. Gibson is a Banting Postdoctoral Fellow at the Center for Innovation in Global Health, at Stanford University School of Medicine. Her research focuses on geopolitical coercion and global maternal child health. Prior to her return to academia, she spent a decade working in global health in countries such as Madagascar, Yemen, Saudi Arabia, and Ecuador.
-
Jessica Grembi
Postdoctoral Scholar, Infectious Diseases
BioEnvironmental enteric dysfunction (EED) affects 50-90% of children in low-income countries and is likely an important factor in child stunting as it impedes efficient nutrient uptake in the small intestine. EED is suspected to be the result of persistent exposure to enteric pathogens, although it has not been correlated with any specific pathogen. My research explores the interplay of gut microbiota, including enteric pathogens, and the host immune system with a focus on understanding EED so we can rationally design treatments and preventive measures.
-
Meghan Halley
Sr Research Scholar, School of Medicine - Biomedical Ethics
BioMeghan Halley, PhD, MPH, is a Senior Research Scholar in the Center for Biomedical Ethics (SCBE) at Stanford University. She completed her doctorate in medical anthropology from Case Western Reserve University in 2012, and additional training in health services research at the Palo Alto Medical Foundation Research Institute from 2012 through 2016. Her current research focuses at the intersection of the ethics and economics of new genomic technologies. Her current projects include examining ethical issues related to sustainability and governance of patient data and relationships when large clinical genomic studies transition to new models of funding; ethnographic work exploring how diverse stakeholders perceive value in the use of genome sequencing for diagnosis of rare diseases; and the development of new measures for assessing patient-centered outcomes in pediatric rare diseases.
